Page 9 - Read Online

49 Hypofractionated ablative radiation therapy for hepatocellular carcinoma: practical
considerations and review of the literature
Marsha Reyngold, Eugene J. Koay, Christopher H. Crane
Hepatoma Res 2018;4:49 http://dx.doi.org/10.20517/2394-5079.2018.84

50 Hepatic resection for hepatocellular carcinoma
Shun Yamaguchi, Taichiro Kosaka, Susumu Eguchi
Hepatoma Res 2018;4:50 http://dx.doi.org/10.20517/2394-5079.2018.68

51 Cancer immunotherapy for hepatocellular carcinoma
Joo-Ho Lee, Soo-Yeon Oh, Jin Yong Kim, Naoshi Nishida
Hepatoma Res 2018;4:51 http://dx.doi.org/10.20517/2394-5079.2018.78

52 The fibroblast growth factor receptor pathway in hepatocellular carcinoma
Joycelyn Jie Xin Lee, Su Pin Choo
Hepatoma Res 2018;4:52 http://dx.doi.org/10.20517/2394-5079.2018.42

53 Thermal ablation of large unresectable hepatocellular carcinoma in cirrhotic patients
Giovan Giuseppe Di Costanzo, Raffaella Tortora, Anna Opramolla, Marco Guarracino
Hepatoma Res 2018;4:53 http://dx.doi.org/10.20517/2394-5079.2018.56

54 HCV-discovery to elimination, “myth or reality”
Wasim Jafri, Basit Siddiqui, Safia Awan
Hepatoma Res 2018;4:54 http://dx.doi.org/10.20517/2394-5079.2018.36

55 Mechanisms and clinical behavior of hepatocellular carcinoma in HBV and HCV infection and
alcoholic and non-alcoholic fatty liver disease
Riccardo Nevola, Luca Rinaldi, Mauro Giordano, Aldo Marrone, Luigi Elio Adinolfi
Hepatoma Res 2018;4:55 http://dx.doi.org/10.20517/2394-5079.2018.38

56 Adult African Americans undergoing cadaveric liver transplantation for hepatocellular
carcinoma within the Milan criteria have the lowest 5-year survival among all the ethnic groups
in the United States: analysis of USA national data between January 2002 and June 2013
Michele Molinari, Subhashini Ayloo, Allan Tsung, Patrick Bou Samra, Naudia Jonaissaint
Hepatoma Res 2018;4:56 http://dx.doi.org/10.20517/2394-5079.2018.71

57 New insights on hepatocellular carcinoma: epidemiology and clinical aspects
Claudio Puoti
Hepatoma Res 2018;4:57 http://dx.doi.org/10.20517/2394-5079.2018.67

58 Staging of hepatocellular carcinoma
Sedat Karademir
Hepatoma Res 2018;4:58 http://dx.doi.org/10.20517/2394-5079.2018.40